Found 182 clinical trials
Venetoclax + Decitabine vs. "7+3" Induction Chemotherapy in Young AML
This research is being done to assess the therapeutic efficacy and safety of a promising (venetoclax and decitabine) versus conventional "7+3"chemotherapy in induction young patients with acute
- 0 views
- 13 Mar, 2022
- 1 location
Study of Enasidenib and Venetoclax in IDH2-Mutated Blood Cancers
The purpose of this research study is to see how safe and tolerable, and to find the highest or best dose, of an investigational combination of drugs called enasidenib and venetoclax, in
- 0 views
- 06 Dec, 2021
- 2 locations
Loncastuximab Tesirine and Venetoclax for Relapsed/ Refractory Non-Hodgkin Lymphoma
The purpose of this study is to determine the correct dose and safety of combining two new cancer drugs, loncastuximab tesirine and venetoclax, as a treatment for relapsed or refractory B cell
- 0 views
- 05 Jun, 2022
- 1 location
Acalabrutinib, Venetoclax, and Obinutuzumab for Initial Therapy of CLL (AVO)
This research study is evaluating the combination of three drugs - acalabrutinib, venetoclax, and obinutuzumab -- as a possible treatment for chronic lymphocytic leukemia (CLL). The drugs
- 233 views
- 19 Jun, 2022
- 3 locations
A Study of Venetoclax and Rituximab/Hyaluronidase Human in Relapsed/Refractory CLL
This is an open-label, multicenter, Phase II study to investigate the efficacy and safety of venetoclax in combination with Rituximab/hyaluronidase human in participants with relapsed or
- 7 views
- 28 Feb, 2022
- 2 locations
Venetoclax Add in Combination With Fludarabine, Cyratabine and Idarubicine in Induction for Acute Myelid Leukemia (V-FIRST)
This study will test the effectiveness and safety of Venetoclax in combination with standard induction regimen for patients with acute leukemia and poor prognosis.
- 2 views
- 12 Mar, 2022
- 13 locations
Duvelisib and Venetoclax in Relapsed or Refractory CLL or SLL or RS
This research study is assessing a new drug, duvelisib, in combination with a drug that is already FDA approved, venetoclax, as a possible treatment for participants with CLL or those with
- 21 views
- 05 Mar, 2022
- 6 locations
Venetoclax, Cladribine, Low Dose Cytarabine, and Azacitidine in Treating Patients With Previously Untreated Acute Myeloid Leukemia
This phase II trial studies how well venetoclax, cladribine, low dose cytarabine, and azacitidine work in treating patients with acute myeloid leukemia that has previously not been treated
- 19 views
- 22 Mar, 2022
- 1 location
Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL
This research study is studying a medication called Venetoclax and a chemotherapy regimen as a possible treatment for Acute Lymphoblastic Leukemia. The drugs involved in this study are
- 3 views
- 01 Feb, 2022
- 2 locations
Venetoclax and Azacitidine for Non-Elderly Adult Patients With Acute Myeloid Leukemia
This study aims to treat non-elderly adult patients, who were previously untreated for acute myeloid leukemia, using venetoclax and azacitidine.
- 7 views
- 15 Mar, 2022
- 1 location